(Q51107407)

30 March 2018

title

Ritanserin facilitates anxiety in a simulated public-speaking paradigm. (English)

1 reference

30 March 2018

author

Bill Deakin

series ordinal

3

1 reference

30 March 2018

author name string

F S Guimarães

series ordinal

1

1 reference

30 March 2018

P S Mbaya

series ordinal

2

1 reference

30 March 2018

language of work or name

English

0 references

publication date

1 January 1997

1 reference

30 March 2018

Journal of Psychopharmacology

published in

1 reference

30 March 2018

volume

11

1 reference

30 March 2018

issue

3

1 reference

30 March 2018

page(s)

225-231

1 reference

30 March 2018

Animal models of anxiety based on classical conditioning: the conditioned emotional response (CER) and the fear-potentiated startle effect

cites work

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100305

5HT2 receptors, depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100305

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100305

THE DEVELOPMENT OF A SCALE TO MEASURE FEAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100305

Effect of metergoline on human anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100305

Effect of chlorimipramine and maprotiline on experimental anxiety in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100305

Characterization of a psychophysiological model of classical fear conditioning in healthy volunteers: influence of gender, instruction, personality and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100305

Effects of ritanserin on aversive classical conditioning in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100305

Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100305

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100305

Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100305

Differential mechanisms involved in the anticonflict action of benzodiazepines injected into the central amygdala and mammillary body.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100305

Simulated public speaking as a model of clinical anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100305

Sensations Evoked by Stimulation in the Midbrain of Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100305

The action of sedatives on brain stem oculomotor systems in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100305

Fenfluramine provocation of anxiety in patients with panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100305

10.1177/026988119701100305

21 January 2018

Identifiers

DOI

1 reference

30 March 2018

PubMed ID

9305414

1 reference

30 March 2018